Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week
- R. Ferreiro-Iglesias,
- A. Jardi,
- ,
- I. Baston,
- J. Gonzalez,
- J. M. Giraldez
Research Output:
Contribution to journal
Meeting Abstract
Peer-reviewPublication Information
Output type
Research Output:
Contribution to journal
Meeting Abstract
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages S390-S391Journal (Volume, Issue Number)
Journal of Crohn's and Colitis (Volume 13)Publication milestones
- Published - 03/2019
Publication status
Published - 03/2019
ISSN
1873-9946Publication IDs
- WOS: 000460544502109
